CL vs KVUE
Colgate Palmolive Co (CL) and Kenvue Inc. (KVUE) are both filed with the SEC under Perfumes, Cosmetics & Other Toilet Preparations. CL is 2.0× KVUE's size by market cap ($72.5B against $36.9B); CL trades at the higher fiscal-year P/E (34.6× against 25.3×); CL reports the higher net margin (10.5% against 9.7%); CL grew sales faster over three years (+4.3% against +0.4%); and over the past year CL returned +10.9% against KVUE's -3.3%.
| CL | KVUE | |
|---|---|---|
| Last close | $90.75 | $19.17 |
| Market cap | $72.5B | $36.9B |
| P/E (FY) | 34.6× | 25.3× |
| P/S | 3.6× | 2.4× |
| EV/EBITDA | 20.1× | 15.2× |
| Gross margin | 60.1% | 58.1% |
| Operating margin | 16.2% | 16.0% |
| Net margin | 10.5% | 9.7% |
| Return on equity | 1603.0% | 14.4% |
| Sales growth (3y) | +4.3% | +0.4% |
| EPS growth (3y) | +7.3% | -14.1% |
| Dividend yield | — | 4.3% |
| 1-year return | +10.9% | -3.3% |
Screener snapshot — prices as of 2026-08-28. Each side's last close is the most recent session the snapshot holds for that company, which can be an earlier one, and its 1-year return is measured to that close. Market caps struck on 2026-08-27. Last close, market cap and the 1-year return are price figures; every other row is computed over the company's latest filed fiscal year, and the two differ: CL FY2025 (ended 2025-12-31); KVUE FY2025 (ended 2025-12-28). A return on equity past ±100% — CL at 1603.0% — divides earnings by an average filed equity base smaller in magnitude than the earnings themselves; the two columns are not on one scale. — not published for this company. A ratio goes unpublished for more than one reason: a component the calculation needs is not on file, the filing does not tag the line it is read from, or the calculation is not defined on the filed basis — EV/EBITDA is not printed on non-positive EBITDA, and return on equity is not computed on a zero or negative equity base.
Who holds them, and who has traded them
| CL | KVUE | |
|---|---|---|
| Institutional holders (13F) | 1,934 | 1,009 |
| Insider buyers − sellers (180d) | -2 | -2 |
| Congressional trades disclosed (180d) | 0 | 5 |
| Executive-branch officials on file — trades disclosed (180d) | 8 | 8 |
Counts only. The congressional figures count transactions dated in the trailing 180 days and disclosed in STOCK Act periodic transaction reports; amounts are filed as ranges and are never summed. The executive-branch figures count the same window of transactions, and they are scoped to one roster. The officials OGE posts for direct download. Insider buyers − sellers counts distinct people filing open-market Form 4 purchases minus distinct people filing open-market sales over the trailing 180 days, capped at ±5.
CL vs KVUE: common questions
- Is CL bigger than KVUE?
- CL carries the larger market cap — $72.5B against $36.9B, both struck on 2026-08-27.
- Which trades at a higher P/E, CL or KVUE?
- CL, at a fiscal-year 34.6× against 25.3× for KVUE. Both are price ÷ latest full-year diluted earnings per share, not a trailing-twelve-month P/E.
- How have CL and KVUE performed over the past year?
- CL returned +10.9% and KVUE -3.3%, measured on the trailing calendar year to the last close.
- How many institutions hold CL and KVUE?
- 1,934 13F filers report a position in CL and 1,009 in KVUE, on the latest quarter in the panel.
- Are CL and KVUE in the same industry?
- Both are filed with the SEC under Perfumes, Cosmetics & Other Toilet Preparations, which is the classification this pairing is built on.
CL overview → · KVUE overview → · CL institutional ownership → · KVUE institutional ownership → · Congress and KVUE → · Executive branch and CL → · Executive branch and KVUE →
Stock comparisons lists every pair this site publishes.
Source: SPZCO — https://spzco.com/vs/cl-vs-kvue